 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
The Journal of Neuroscience, February 4, 2009, 29(5):1457-1468; doi:10.1523/JNEUROSCI.4688-08.2009
This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager 
Citing Articles Citing Articles via Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Ledoux, V. A. Articles by Woolley, C. S. Search for Related Content PubMed PubMed Citation Articles by Ledoux, V. A. Articles by Woolley, C. S. Pubmed/NCBI databases
Compound via MeSH
Hazardous Substances DB Medline Plus Health Information
Previous Article | Next Article
Behavioral/Systems/Cognitive
Estradiol Facilitates the Release of Neuropeptide Y to Suppress Hippocampus-Dependent Seizures
Veronica A. Ledoux, * Tereza Smejkalova, * Renee M. May, Bradley M. Cooke, andCatherine S. Woolley Department of Neurobiology and Physiology, Northwestern University, Evanston, Illinois 60208
Correspondence should be addressed to Catherine S. Woolley, 2205 Tech Drive, Northwestern University, Evanston, IL 60208. Email: cwoolley{at}northwestern.edu
About one-third of women with epilepsy have a catamenial seizure pattern, in which seizures fluctuate with the menstrual cycle. Catamenial seizures occur more frequently when the ratio of circulating estradiol to progesterone is high, suggesting that estradiol is proconvulsant. We used adult female rats to test how estradiol-induced suppression of GABAergic inhibition in the hippocampus affects behavioral seizures induced by kainic acid. As expected, estradiol decreased the latency to initiate seizures, indicating increased seizure susceptibility. At the same time, however, estradiol also shortened the duration of late-stage seizures, indicating decreased seizure severity. Additional analyses showed that the decrease in seizure severity was attributable to greater release of the anticonvulsant neuropeptide, neuropeptide Y (NPY). First, blocking hippocampal NPY during seizures eliminated the estradiol-induced decrease in seizure duration. Second, light and electron microscopic studies indicated that estradiol increases the potentially releasable pool of NPY in inhibitory presynaptic boutons and facilitates the release of NPY from inhibitory boutons during seizures. Finally, the presence of estrogen receptor-
on large dense-core vesicles (LDCVs) in the hippocampus suggests that estradiol could facilitate neuropeptide release by acting directly on LDCVs themselves. Understanding how estradiol regulates NPY-containing LDCVs could point to molecular targets for novel anticonvulsant therapies.
Key words: catamenial epilepsy; CA1; GABA; large dense-core vesicle; kainic acid; electron microscopy
Received Sept. 30, 2008; revised Dec. 15, 2008; accepted Dec. 19, 2008.
Correspondence should be addressed to Catherine S. Woolley, 2205 Tech Drive, Northwestern University, Evanston, IL 60208. Email: cwoolley{at}northwestern.edu
|
|
|
|
 |
|